| 发明名称 | PC-O 44:4—a biomarker for visceral adiposity | ||
| 摘要 | The present invention generally relates to the field of biomarkers. In particular, the present invention relates to biomarkers such as PC-O 44:4 that can be used, for example for detecting and/or quantifying visceral adiposity and/or changes in visceral adiposity. This biomarker may also be used to diagnosing the effect of a change in lifestyle on visceral adiposity in a subject. | ||
| 申请公布号 | US9261520(B2) | 申请公布日期 | 2016.02.16 |
| 申请号 | US201414553133 | 申请日期 | 2014.11.25 |
| 申请人 | NESTEC S.A. | 发明人 | Martin Francois-Pierre;Montoliu Roura Ivan;Guy Philippe Alexandre;Rezzi Serge Andre Dominique |
| 分类号 | G01N33/92;G01N33/48;C07F9/09 | 主分类号 | G01N33/92 |
| 代理机构 | Kilpatrick Townsend & Stockton LLP | 代理人 | Kilpatrick Townsend & Stockton LLP |
| 主权项 | 1. A method of diagnosing the effect of a change in lifestyle on visceral adiposity in a subject, comprising: determining a level of PC-O 44:4 in a body fluid sample previously obtained from a subject to be tested after the change in lifestyle, and comparing the subject's PC-O 44:4 level to a predetermined reference value, wherein the predetermined reference value is based on a PC-O 44:4 level in the same body fluid obtained from the same subject prior to the lifestyle change, and wherein an increased PC-O 44:4 level in the sample compared to the predetermined reference value indicates a positive effect of the change in lifestyle on visceral adiposity. | ||
| 地址 | Vevey CH | ||